chartexchange

SKYE
Skye Bioscience, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:39 PM EST
1.00USD0.000%(0.00)16,541
After-hoursNov 18, 2026 4:00:30 PM EST
1.03USD+3.000%(+0.03)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$1.00
Beta
0.63
52-Week High
$11.04 2025-11-28
52-Week Low
$0.50 2026-11-09
SMA 50
$1.49
SMA 200
$4.41
Avg. Vol 10D
222,153
Avg. Vol 30D
89,936
Avg. Vol 90D
92,268
Relative Vol
0.18
3.14M
3.6400%
Aug 24, 2026 · 1-for-8 (reverse)
SKYE Profile

nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.

SKYE Performance
PeriodPriceDateChangeBeta
1W1.082026-11-12-7.41%3.163
1M1.532026-10-19-34.64%-0.826
3M2.452026-08-19-59.14%-0.775
6M5.802026-05-19-82.76%-0.288
1Y10.482025-11-19-90.46%0.632
2Y34.722024-11-19-97.12%—
5Y104.002021-12-31-99.04%0.297
SKYE Stock Summary

Skye Bioscience, Inc. Common Stock (NASDAQ:SKYE) stock price today is $1.00, and today's volume is 16,541. SKYE is up 0.000% today. The 30 day average volume is 89,936. SKYE market cap is $4.42M with 4.42M shares outstanding.